| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698413 | Clinical Oncology | 2015 | 6 Pages |
Abstract
In view of these results, we suggest that brachytherapy should be considered as a suitable treatment option for treating pelvic malignancy in patients with inflammatory bowel disease, whereas EBRT should be used with caution.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
D. Tromp, D.R.H. Christie,